Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions.
Eustachio AgricolaFrancesco AnconaThomas BartelEric BrochetMarc DweckFrancesco FaletraPatrizio LancellottiHani Mahmoud-ElsayedNina Ajmone MarsanPal Maurovich-HovartMark MonaghanGianluca PontoneLeyla Elif SadeMartin SwaansRalph Stephan von BardelebenNina WunderlichJose-Luis ZamoranoBogdan A PopescuBernard CosynsErwan DonalPublished in: European heart journal. Cardiovascular Imaging (2023)
Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded dramatically over the last years, thanks to the developments and improvements of devices and imaging techniques, along with the increasing expertise of operators. Imaging, in particular echocardiography, is pivotal during patient selection, procedural monitoring, and follow-up. The imaging assessment of patients undergoing transcatheter interventions places demands on imagers that differ from those of the routine evaluation of patients with SHD, and there is a need for specific expertise for those working in the cath lab. In the context of the current rapid developments and growing use of SHD therapies, this document intends to update the previous consensus document and address new advancements in interventional imaging for access routes and treatment of patients with aortic stenosis and regurgitation, and mitral stenosis and regurgitation.
Keyphrases
- aortic stenosis
- high resolution
- transcatheter aortic valve implantation
- mitral valve
- aortic valve
- patients undergoing
- left ventricular
- transcatheter aortic valve replacement
- aortic valve replacement
- ejection fraction
- pulmonary hypertension
- computed tomography
- physical activity
- heart failure
- photodynamic therapy
- clinical practice
- mass spectrometry
- coronary artery disease
- combination therapy
- fluorescence imaging